NuVision
NuVision™ is a spin-out company from the University of Nottingham, incorporated July 2014. The company was established to commercialise high quality and affordable biotherapies for treating ‘front of the eye’ disease and trauma. Dr Andrew Hopkinson, the Principal Research Fellow in Academic Ophthalmology, Division of Clinical Neuroscience at the University of Nottingham, founded NuVision™. The business is co-owned by the founders, Dr Andrew Hopkinson (Chief Scientific Officer), Professor Harminder Dua (co-founder), the directors Mr Byran Lister (CEO) and Dr Helen Shaw (Chairman), and the University of Nottingham.
Domain
nu-vision.co.uk
Country
United KingdomIndustry
BiotechnologyEmployees
11-50
Last Funding
$6.5M
Founded
2014
No technologies detected yet for this company.
Frequently Asked Questions
What technologies does NuVision use?+
We have not yet detected technologies for NuVision.
What industry is NuVision in?+
NuVision operates in the Biotechnology industry.
Where is NuVision based?+
NuVision is headquartered in United Kingdom.
Explore More
Need this data at scale?
Get ready-to-use datasets: companies, technologies, and tech adoption signals across 3M+ websites.
Browse DatasetsData last updated: June 2026